Valentina mosienko, Biologist

Washington [US], April 27 : An international team of scientists discovered a gene in the brain that is responsible for anxious feelings. Importantly, gene alteration has been found to decrease anxiety levels, providing an attractive new therapeutic target for anxiety disorders.The discovery, led by researchers at the Universities of Bristol and Exeter, is published online in Nature Communications.Anxiety disorders are common with 1 in 4 people diagnosed with a disorder at least once in their lifetime. Severe psychological trauma can trigger genetic, biochemical and morphological changes in neurons in the brain's amygdala the brain region implicated in stress-induced anxiety, leading to the onset of anxiety disorders, including pc attacks and post-traumatic stress disorder.However, the efficacy of currently available anti-anxiety drugs is low with more than half of patients not achieving remission following treatment. Limited success in developing potent anxiolytic (anti-anxiety) drugs is a result of our poor understanding of the neural circuits underlying anxiety and molecular events resulting in stress-related neuropsychiatric states.In this study, scientists sought to identify the molecular events in the brain that underpin anxiety. They focused on a group of molecules, known as miRNAs in mal models. This important group of molecules, also found in the human brain, regulates multiple target proteins controlling the cellular processes in the amygdala.Following acute stress, the team found an increased amount of one type of molecule called miR483-5p in a mouse amygdala. Importantly, the team showed that increased miR483-5p suppressed the expression of another gene, Pgap2, which in turn drives changes to neuronal morphology in the brain and behaviour associated with anxiety. Together, the researchers showed that miR-483-5p acts as a molecular brake that offsets stress-induced amygdala changes to promote anxiety relief.The discovery of a novel amygdala miR483-5p/Pgap2 pathway through which the brain regulates its response to stress is the first stepping stone towards the discovery of novel, more potent and much-needed treatments for anxiety disorders that will enhance this pathway.Dr Valentina Mosienko, one of the study's lead authors and an MRC Fellow and Lecturer in Neuroscience in Bristol's School of Physiology, Pharmacology and Neuroscience, said: "Stress can trigger the onset of a number of neuropsychiatric conditions that have their roots in an adverse combination of genetic and environmental factors. While low levels of stress are counterbalanced by the natural capacity of the brain to adjust, severe or prolonged traumatic experiences can overcome the protective mechsms of stress resilience, leading to the development of pathological conditions such as depression or anxiety."miRNAs are strategically poised to control complex neuropsychiatric conditions such as anxiety. But the molecular and cellular mechsms they use to regulate stress resilience and susceptibility were until now, largely unknown. The miR483-5p/Pgap2 pathway we identified in this study, activation of which exerts anxiety-reducing effects, offers a huge potential for the development of anti-anxiety therapies for complex psychiatric conditions in humans."Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Valentina MosienkoFOLLOW

Valentina mosienko, Latest News

Technology :Scientists identify a gene in brain that might reduce anxiety

Washington [US], April 27 : An international team of scientists discovered a gene in the brain that is responsible ... ...